The effect of consumption of citrus fruit and olive leaf extract on lipid metabolism

Nutrients

Volumn 9, Issue 10, 2017, Pages

  Merola, Nicola ^a   Castillo, Julián ^b   Benavente García, Obdulio ^b   Ros, Gaspar ^a   Nieto, Gema ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b 80320 Alcantarilla   (Spain)

Author keywords

Cholesterol; Flavonoids; FOT Fat Oral Test; Oleuropein; Olive and citrus extract; Phenolics; Weight control

Indexed keywords

ACTEOSIDE; ALANINE AMINOTRANSFERASE; APIGETRIN; ASPARTATE AMINOTRANSFERASE; AURANTIIN; BILE SALT; CAFFEIC ACID; CHOLESTEROL; CITROLIVE; CITRUS FRUIT EXTRACT; DIOSMETIN; GLUCOSE; HESPERIDIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYTYROSOL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; NEOHESPERIDIN; OLEUROPEIN; OLIVE LEAF EXTRACT; PLANT EXTRACT; SECOIRIDOID; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TYROSOL; UNCLASSIFIED DRUG; VANILLIC ACID; ANTIOBESITY AGENT; BIOLOGICAL MARKER; LACTONE; LIPID; TETRAHYDROLIPSTATIN;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC50; LIPID DIET; LIPID METABOLISM; MALE; NONHUMAN; OBESITY; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMISTRY; CITRUS; DISEASE MODEL; DRUG EFFECT; FECES; FRUIT; ISOLATION AND PURIFICATION; METABOLISM; OLIVE TREE; PLANT LEAF; POSTPRANDIAL STATE; TIME FACTOR; WISTAR RAT;

ANIMALS; ANTI-OBESITY AGENTS; BIOMARKERS; CHOLESTEROL; CITRUS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FECES; FRUIT; LACTONES; LIPASE; LIPID METABOLISM; LIPIDS; LIPOPROTEINS, LDL; MALE; OBESITY; OLEA; PLANT EXTRACTS; PLANT LEAVES; POSTPRANDIAL PERIOD; RATS, WISTAR; TIME FACTORS; TRIGLYCERIDES;

EID: 85030179012     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9101062     Document Type: Article

References (26)

1. Mitchell, N.S., Catenacci, V.A., Wyatt, H.R., Hill, J.O. Obesity: Overview of an Epidemic. Psychiatr. Clin. N. Am. 2011, 34, 717-732.
2. Sun, B., Karin, M. Obesity, inflammation, and liver cancer. J. Hepatol. 2012, 56, 704-713.
3. Ferramosca, A., Conte, A., Damiano, F., Siculella, L., Zara, V. Differential effects of high-carbohydrate and high-fat diets on hepatic lipogenesis in rats. Eur. J. Nutr. 2014, 53, 1103-1114.
4. Borén, J., Matikainen, N., Adiels, M., Taskinen, M.R. Postprandial hypertriglyceridemia as a coronary risk factor. Clin. Chim. Acta 2014, 431, 131-142.
5. Cannon, C.P., Kumar, A. Treatment of overweight and obesity: Lifestyle, pharmacologic, and surgical options. Clin. Cornerstone 2009, 9, 55-71.
6. Wyatt, H.R. Update on treatment strategies for obesity. J. Clin. Endocrinol. Metab. 2013, 98, 1299-1306.
7. Vermerris, W., Nicholson, R. Phenolic Compound Biochemistry, Springer: Dordrecht, The Netherlands, 2007, pp. 202-227.
8. Yun, J.W. Possible anti-obesity therapeutics from nature-a review. Phytochemistry 2010, 71, 1625-1641.
9. Agostoni, C., Bresson, J.-L., Fairweather-Tait, S., Flynn, A., Golly, I., Korhonen, H., Lagiou, P., Løvik, M., Marchelli, R., Martin, A., et al. Olive, polyphenols, LDL, HDL, cholesterol, oxidative damage, blood pressure, inflammation, upper respiratory tract, gastrointestinal tract, body defences, external agents, health claims. EFSA J. 2011, 9, 2033-2058.
10. Therios, I. Oleuropein, olive leaf extract, olive oil and the benefits of the Mediterranean diet to human health. In Olives, Chapter 26, Olive Mill Products and Environmental Impact of Olive Oil Production, Therios, I., Ed., CABI:Wallingford, UK, 2008, pp. 303-317.
11. Benavente-García, O., Castillo, J. Update on uses and properties of citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agric. Food Chem. 2008, 56, 6185-6205.
12. Raasmaja, A., Lecklin, A., Li, X.M., Zou, J., Zhu, G.G., Laakso, I., Hiltunen, R. A water-alcohol extract of Citrus grandis whole fruits has beneficial metabolic effects in the obese Zucker rats fed with high fat/high cholesterol diet. Food Chem. 2013, 138, 1392-1399.
13. Nakai, M., Fukui, Y., Asami, S., Toyoda-Ono, Y., Iwashita, T., Shibata, H., Kiso, Y. Inhibitory effects of oolong tea biophenols on pancreatic lipase in vitro. J. Agric. Food Chem. 2005, 53, 4593-4598.
14. Merola, N., Medrano Chávez, A., Ros, G. Oral lipid loading test inWistar rats as a reliable method for the study of the triacylglycerol malabsorption. An. Vet. Murcia 2011, 27, 65-72.
15. Al-Suwailem, A.K., Al-Tamimi, A.S., Al-Omar, M.A., Al-Suhibani, M.S. Safety and Mechanism of Action of Orlistat (Tetrahydrolipstatin) as the First Local Antiobesity Drug. J. Appl. Sci. Res. 2006, 2, 205-208.
16. Argmann, C.A., Houten, S.M., Champy, M.-F., Auwerx, J. Lipid and bile acid analysis. In Current Protocols in Molecular Biology, Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Struhl, K., Eds., John Wiley & Sons: Hoboken, NJ, USA, 2006, Chapter 29.
17. Kiortsis, D.N., Filippatos, T.D., Elisaf, M.S. The effects of Orlistat on metabolic parameters and other cardiovascular risk factors. Diabetes Metab. 2005, 31, 15-22.
18. Lairon, D., Lopez-Miranda, J., Williams, C. Methodology for studying postprandial lipid metabolism. Eur. J. Clin. Nutr. 2007, 61, 1145-1161.
19. Birari, R.B., Bhutani, K.K. Pancreatic lipase inhibitors from natural sources: Unexplored potential. Drug Discov. Today 2007, 12, 879-889.
20. Rajaratnam, R.A., Gylling, H., Miettinen, T.A. Cholesterol absorption, synthesis, and faecal output in postmenopausal women with and without coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1650-1655.
21. Cohen, D.E. Balancing cholesterol synthesis and absorption in the gastrointestinal tract. J. Clin. Lipidol. 2008, 2, S1-S3.
22. Ros, E. Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk. Atherosclerosis 2000, 151, 357-379.
23. Hur, W., Kim, S.W., Lee, Y.K., Choi, J.E., Hong, S.W., Song, M.J., Bae, S.H., Park, T., Um, S.J., Yoon, S.K. Oleuropein reduces free fatty acid-induced lipogenesis via lowered extracellular signal-regulated kinase activation in hepatocytes. Nutr. Res. 2012, 32, 778-786.
24. Oi-Kano, Y., Kawada, T., Watanabe, T., Koyama, F., Watanabe, K., Senbongi, R., Iwai, K. Extra virgin olive oil increases uncoupling protein 1 content in brown adipose tissue and enhances noradrenaline and adrenaline secretions in rats. J. Nutr. Biochem. 2007, 18, 685-692.
25. Polzonetti, V., Natalini, P., Vincenzetti, S., Vita, A., Pucciarelli, S. Olives and Olive Oil in Health and Disease Prevention. In Modulatory Effect of Oleuropeinon Digestive Enzymes, Preedy, V.R., Watson, R.R., Eds., Academic Press: San Diego, CA, USA, 2010, pp. 1327-1333, Chapter 14.
26. Postic, C., Girard, J. The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab. 2008, 34, 643-648.